The scientist’s investigation covers issues in Immunology, Complement system, Cell biology, Antibody and Complement membrane attack complex. Francesco Tedesco has researched Immunology in several fields, including Placenta and Glycoprotein. His biological study spans a wide range of topics, including Hematology and Complement.
His Cell biology research incorporates elements of Cell adhesion, E-selectin and Classical complement pathway. His research in Antibody tackles topics such as In vivo which are related to areas like Immunotherapy, CD20, Pharmacology and Monoclonal antibody. His research in Rituximab intersects with topics in Cancer research and Antibody-dependent cell-mediated cytotoxicity, Cytotoxicity.
Francesco Tedesco mainly investigates Immunology, Complement system, Antibody, Cell biology and Molecular biology. His work on Trophoblast expands to the thematically related Immunology. The various areas that Francesco Tedesco examines in his Complement system study include Internal medicine, Biochemistry and Mannan-binding lectin.
His work deals with themes such as In vivo and Antigen, which intersect with Antibody. His Antigen research focuses on subjects like Cytotoxicity, which are linked to Cancer research. He works mostly in the field of Cell biology, limiting it down to topics relating to Endothelium and, in certain cases, Endothelial stem cell and Intravital microscopy.
Francesco Tedesco spends much of his time researching Complement system, Immunology, Antibody, Antiphospholipid syndrome and Internal medicine. His Complement system research includes themes of Cancer research, Endothelium, Preeclampsia and Cell biology. His research ties In vivo and Immunology together.
His studies deal with areas such as Antigen, Cytotoxicity, Leukemia, Chronic lymphocytic leukemia and Immunotherapy as well as Antibody. The study incorporates disciplines such as Epitope, Autoantibody, Blood cell and Glycoprotein in addition to Antiphospholipid syndrome. The Internal medicine study combines topics in areas such as Complement membrane attack complex, Endocrinology, Eculizumab and Cardiology.
His main research concerns Complement system, Immunology, Antiphospholipid syndrome, Antibody and Thrombosis. Francesco Tedesco interconnects Internal medicine and Virology in the investigation of issues within Complement system. Francesco Tedesco is studying CD20, which is a component of Immunology.
His Antiphospholipid syndrome research integrates issues from In vitro, Inflammation, Glycoprotein, Phage display and In vivo. His study in Antibody is interdisciplinary in nature, drawing from both Antigen, Cytotoxicity, Leukemia, Chronic lymphocytic leukemia and Immunotherapy. He has included themes like Concomitant, Autoimmunity, Coagulopathy and C-reactive protein in his Thrombosis study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
Josée Golay;Josée Golay;Luisella Zaffaroni;Luisella Zaffaroni;Thomas Vaccari;Thomas Vaccari;Manuela Lazzari;Manuela Lazzari.
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Pier Luigi Meroni;M. Orietta Borghi;Elena Raschi;Francesco Tedesco.
Nature Reviews Rheumatology (2011)
Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT
Barbara Bottazzi;Valérie Vouret-Craviari;Antonio Bastone;Luca De Gioia.
Journal of Biological Chemistry (1997)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement-dependent and requires a priming factor
Fabio Fischetti;Paolo Durigutto;Valentina Pellis;Alessandra Debeus.
The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity
Francesco Tedesco;Mario Pausa;Ermanno Nardon;Martino Introna.
Journal of Experimental Medicine (1997)
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA
M.A. Seelen;A. Roos;J. Wieslander;T.E. Mollnes.
Journal of Immunological Methods (2005)
Inhibiting the C5–C5a receptor axis
Trent M. Woodruff;Kutty S. Nandakumar;Francesco Tedesco.
Molecular Immunology (2011)
Endothelial Cell E- and P-Selectin and Vascular Cell Adhesion Molecule-1 Function as Signaling Receptors
P. Lorenzon;E. Vecile;E. Nardon;E. Ferrero.
Journal of Cell Biology (1998)
Complement in human diseases: Lessons from complement deficiencies.
Marina Botto;Michael Kirschfink;Paolo Macor;Matthew C. Pickering.
Molecular Immunology (2009)
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
Marina Noris;Miriam Galbusera;Sara Gastoldi;Paolo Macor.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: